The positive effects of bile acids-mediated FXR and TGR5 activation in a wide range of metabolic processes, including glucose metabolism and insulin signaling, triglyceride and cholesterol metabolism as well as the inflammation, put the focus of research interest on bile acids to develop effective therapeutic strategies for this liver-associated metabolic disease. The gene discussed is NR1H4; the disease is metabolic disease.